Johnson & Johnson Loses $25 Million Talc Verdict in New York
- Woman claimed at trial J&J’s baby powder caused rare cancer
- J&J also wins defense verdict in South Carolina talc case
Johnson & Johnson Baby Powder
Photographer: Justin Sullivan/Getty Images
This article is for subscribers only.
Johnson & Johnson was ordered to pay at least $25 million to a woman who said she contracted a rare asbestos-related cancer through decades of daily use of J&J’s Baby Powder or its other talc product, Shower to Shower.
The New York verdict for plaintiff Donna Olson, 66, and her husband against J&J and its consumer-products unit only reflects the award of compensatory damages. Jurors will return next week to consider assessing punitive damages against the companies over their mishandling of the talc products.